Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Gao (zhengzhou, China), M. Lonergan (Dundee, United Kingdom), H. Abo-Leyah (Dundee, United Kingdom), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Regis-Burgel (Paris, France), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), E. Polverino (Barcelona, Spain), S. Skrgat (Golnik, Slovenia), M. Van Der Eerden (Rotterdam, Netherlands), W. Boersma (Alkmaar, Netherlands), O. Sibila (Barcelona, Spain), M. Mcdonnell (Galway, Ireland), P. Kauppi (Helsinki, Finland), V. Botnaru (Chisinau, Republic of Moldova), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium), J. Rademacher (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), M. R Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), J. Stuart Elborn (Belfast, United Kingdom), M. L Crichton (Dundee, United Kingdom), P. C Goeminne (Sint Niklaas, Belgium), M. Shteinberg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), J. Altenburg (Amsterdam, Netherlands), J. D Chalmers (Dundee, United Kingdom). Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study. 3336

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: The effects of roxithromycin as anti-inflammatoy agent on clinical outcomes in patient with bronchiectasis: A double blinded randomized controlled study Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011 The role of phonophoresis in patients with COPD: a randomized clinical trial Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Run-in bias in randomised trials: the case of COPD medications Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017 Year: 2017 Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Source: Eur Respir J 2014; 44: 1123-1126 Year: 2014 Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials Source: Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020 Year: 2021 Heterogeneity of treatment response in bronchiectasis clinical trials Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019 Roflumilast for stable COPD: Meta-analysis of randomized controlled trials Source: International Congress 2014 – Clinical presentations Year: 2014 ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017 Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018 Acetylcysteine in treatment of subacute sinusitis, a double blind placebo controlled clinical trial study Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Lower incidence of asthma exacerbations with FENO-guided anti-inflammatory treatment: A randomised controlled trial Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012 Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016 Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis. Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Safety of formoterol in asthma clinical trials: an update Source: Eur Respir J 2014; 43: 103-114 Year: 2004 Patients in randomized clinical trials of bronchiectasis are only partially representative of clinical practice: A European cohort study Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 RCT Abstract - The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID Year: 2021